Drug intelligence / Profile preview

Danshen Oral Liquid

Development stage
Unknown
Lead developer
Wuhan Juneng Jinshi Pharmaceutical
Administration
Oral
01

Overview

Danshen Oral Liquid is an approved traditional Chinese medicine (TCM) formulation developed and manufactured by Wuhan Juneng Golden Key Pharmaceutical Co., Ltd. The primary active ingredient is derived from *Salvia miltiorrhiza* (Danshen). It is indicated for promoting blood circulation, removing blood stasis, soothing the liver, and relieving depression. Clinically, it is utilized as an adjuvant therapy for cardiovascular symptoms including chest stuffiness, chest tightness, and heartache associated with blood congestion, as well as for the treatment of chronic hepatitis B. The product is registered in China under the National Medicine Standard approval number Z20000096 and is supplied as a 10ml oral solution.

Brand names
Danshen Koufuye
Other names
丹参口服液Salvia Oral Liquid
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)Aβ (Amyloid-beta peptides and aggregates)IL-6 (Interleukin 6)Stimulator of interferon genes (STING)-TANK-binding kinase 1 (TBK1) protein-protein interaction complexTP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Danshen Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danshen Oral Liquid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call